House Approves Track-and-Trace, Compounding Reform Bill

A nationwide pharmaceutical track-and-trace program inched closer to reality Saturday on House approval of legislation introduced last week by leaders in both houses of Congress. The bill, known as the Drug Quality and Security Act (H.R. 3204), would also give the FDA new authority over large compounding pharmacies — albeit with certain key caveats. The House version of the bill, which passed on a voice vote, mirrors a Senate version of the bill that will move to the floor of that body as soon as Congress concludes its battle over how to fund the government into the new fiscal year.
Drug Industry Daily